Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111233949A details a novel one-pot three-enzyme method for GM3 synthesis, offering high stereoselectivity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN112574056A reveals a green photocatalytic route for alpha,alpha-difluoro-gamma-hydroxyacetamide derivatives, offering cost-effective manufacturing and scalable supply chain solutions.
Novel patent CN116178386B reveals high-purity LE14 synthesis. Reduces impurities and costs for ADC manufacturing supply chains globally.
Patent CN1013113B details a novel route for N-(thiophen-3-yl)-chloroacetamide precursors. This method offers cost reduction in herbicide manufacturing via efficient cyclization.
Patent CN107721920B details a novel Rh(III)-catalyzed C(sp3)-H amidation. Offers high atom economy and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN112194620B reveals a high-purity route for ethionamide intermediates, eliminating isomers and ensuring cost reduction in API manufacturing.
Advanced synthesis of Repaglinide intermediates via DEPBT coupling. Delivers high optical purity and cost reduction in API manufacturing for global supply chains.
Patent CN105829284A reveals a rapid, water-based method for high-purity adamantane carboxamides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel alkylation process for (2S)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropionic acid derivatives offers high purity and scalable manufacturing for metabolic syndrome drugs.
Patent CN1178921C details a novel route for ethylene glycol sulfonamides, offering reduced steps and improved purity for pharmaceutical manufacturing.
Patent CN116217655A reveals a stable synthesis route for ADC linker intermediate Formula I. Achieve high purity and reduced cytotoxic exposure for reliable supply chains.
Novel patent CN115925598B enables safe thiofluoroformamide production without toxic gases offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN102452981A reveals novel synthesis of 1,3-disubstituted-3-azabicyclo[3,2,1]octanes, offering cost-effective routes for pharmaceutical intermediate manufacturing and supply chain optimization.
Advanced preparation of c-Met inhibitor intermediates via Pd-catalyzed coupling. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Patent CN102020579A reveals a safer diamide synthesis route eliminating acid chloride steps, offering cost reduction in rare earth extractant manufacturing and enhanced supply chain reliability.
Novel synthetic route for Ostopanic acid analogs offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing with high purity standards.
Patent CN103755584B reveals a one-step KOH/DMSO method for alpha-hydroxy amides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN111253448B reveals a novel purification method for NMN intermediates, significantly boosting yield and purity for cost-effective pharmaceutical manufacturing.
Patent CN102020634B reveals a high-yield route for N-(cyanoalkyl) benzamides, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.